Publications

Garcia, J., H. I. Hurwitz, A. B. Sandler, D. Miles, R. L. Coleman, R. Deurloo, and O. L. Chinot. “Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.” Cancer Treatment Reviews 86 (June 1, 2020). https://doi.org/10.1016/j.ctrv.2020.102017.

Full Text

Butt, Julia, William J. Blot, Martha J. Shrubsole, Tim Waterboer, Michael Pawlita, and Meira Epplein. “Differences in antibody levels to H. pylori virulence factors VacA and CagA among African Americans and whites in the Southeast USA.” Cancer Causes Control 31, no. 6 (June 2020): 601–6. https://doi.org/10.1007/s10552-020-01295-z.

PMID
32222845
Full Text

Scheffler, M., A. Holzem, A. Kron, L. Nogova, M. A. Ihle, C. von Levetzow, J. Fassunke, et al. “Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations.” Lung Cancer 144 (June 1, 2020): 40–48. https://doi.org/10.1016/j.lungcan.2020.04.020.

Full Text

Bakthavatsalam, Subha, Petpailin Wiangnak, Daniel J. George, Tian Zhang, and Katherine J. Franz. “Dithiocarbamate prodrugs activated by prostate specific antigen to target prostate cancer.” Bioorg Med Chem Lett 30, no. 11 (June 1, 2020): 127148. https://doi.org/10.1016/j.bmcl.2020.127148.

PMID
32253061
Full Text

Wang, Shuo, Xiaoli Wang, Xinna Zhou, Herbert Kim Lyerly, Michael A. Morse, and Jun Ren. “DC-CIK as a widely applicable cancer immunotherapy.” Expert Opin Biol Ther 20, no. 6 (June 2020): 601–7. https://doi.org/10.1080/14712598.2020.1728250.

PMID
32033522
Full Text

Liu, Xiaowen, Danwen Qian, Hongliang Liu, James L. Abbruzzese, Sheng Luo, Kyle M. Walsh, and Qingyi Wei. “Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancer.” Mol Carcinog, May 5, 2020. https://doi.org/10.1002/mc.23208.

PMID
32367578
Full Text

Kamal, Arif H., Janet H. Bull, Steven P. Wolf, Keith M. Swetz, Tait D. Shanafelt, Katherine Ast, Dio Kavalieratos, and Christian T. Sinclair. “Prevalence and Predictors of Burnout Among Hospice and Palliative Care Clinicians in the U.S.” J Pain Symptom Manage 59, no. 5 (May 2020): e6–13. https://doi.org/10.1016/j.jpainsymman.2019.11.017.

PMID
31778784
Full Text

Sammons, Sarah, Mina S. Sedrak, and Gretchen G. Kimmick. “The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.” Drugs Aging 37, no. 5 (May 2020): 331–48. https://doi.org/10.1007/s40266-020-00748-z.

PMID
32100240
Full Text

Shelby, Rebecca A., Caroline S. Dorfman, Sarah S. Arthur, Hayden B. Bosworth, Leonor Corsino, Linda Sutton, Lynda Owen, et al. “Improving health engagement and lifestyle management for breast cancer survivors with diabetes.” Contemp Clin Trials 92 (May 2020): 105998. https://doi.org/10.1016/j.cct.2020.105998.

PMID
32289471
Full Text

Najjar, O., A. Varghese, M. Shahi, R. Vang, S. Gaillard, T. Smith, and A. N. Fader. “Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report.” Gynecologic Oncology Reports 32 (May 1, 2020). https://doi.org/10.1016/j.gore.2020.100555.

Full Text

Pages